Free Trial

Ardent Health Partners, LLC's Lock-Up Period Set To Expire on January 14th (NYSE:ARDT)

Ardent Health Partners logo with Medical background

Ardent Health Partners' (NYSE:ARDT - Get Free Report) lock-up period will end on Tuesday, January 14th. Ardent Health Partners had issued 12,000,000 shares in its public offering on July 18th. The total size of the offering was $192,000,000 based on an initial share price of $16.00. After the expiration of Ardent Health Partners' lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company will be lifted.

Analyst Ratings Changes

A number of equities analysts have commented on ARDT shares. Royal Bank of Canada reissued an "outperform" rating and issued a $23.00 price objective on shares of Ardent Health Partners in a research note on Thursday, November 14th. Truist Financial reduced their price target on shares of Ardent Health Partners from $22.00 to $21.00 and set a "buy" rating on the stock in a research report on Monday. KeyCorp initiated coverage on shares of Ardent Health Partners in a research note on Friday, October 11th. They issued an "overweight" rating and a $24.00 target price for the company. Bank of America lowered shares of Ardent Health Partners from a "buy" rating to a "neutral" rating and reduced their target price for the stock from $22.00 to $19.00 in a research report on Wednesday, November 6th. Finally, JPMorgan Chase & Co. reissued a "neutral" rating and issued a $20.00 price target on shares of Ardent Health Partners in a report on Tuesday, December 17th. Two analysts have rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Buy" and an average target price of $22.00.

Check Out Our Latest Research Report on Ardent Health Partners

Ardent Health Partners Price Performance

Shares of Ardent Health Partners stock traded up $0.43 during trading on Tuesday, hitting $16.35. 178,645 shares of the company were exchanged, compared to its average volume of 269,561. The company has a current ratio of 1.91, a quick ratio of 1.78 and a debt-to-equity ratio of 0.78. The stock has a fifty day moving average price of $16.66. Ardent Health Partners has a 1-year low of $14.57 and a 1-year high of $20.72.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of ARDT. Wellington Management Group LLP acquired a new position in shares of Ardent Health Partners in the 3rd quarter valued at approximately $28,724,000. Point72 Asset Management L.P. bought a new position in Ardent Health Partners in the third quarter valued at approximately $27,428,000. Goldentree Asset Management LP acquired a new position in shares of Ardent Health Partners in the third quarter valued at approximately $22,897,000. Franklin Resources Inc. bought a new stake in shares of Ardent Health Partners during the third quarter worth $15,839,000. Finally, Allspring Global Investments Holdings LLC acquired a new stake in shares of Ardent Health Partners during the third quarter worth $13,119,000.

About Ardent Health Partners

(Get Free Report)

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.

Featured Articles

Should You Invest $1,000 in Ardent Health Partners Right Now?

Before you consider Ardent Health Partners, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ardent Health Partners wasn't on the list.

While Ardent Health Partners currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines